executive director for Maxicare Philadelphia, and deputy director for the U.S. Public Health Service.

DIA's search committee worked with executive search firm Korn/Ferry International to find the most qualified candidate to lead DIA into the 21st century. "The requirements for the position of DIA worldwide executive director have evolved and are particularly challenging," says Marie A. Dray, DIA immediate-past president and chair of the search committee. "The position requires experience as an association leader, understanding of the challenges of membership building, skill in training and educational program development, not to mention state-of-the-art knowledge of global healthcare changes. That really is a tall order, but one we're confident we have filled with the hiring of Paul Pomerantz."

About the Drug Information Association (DIA) As a nonprofit member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Back to HCB News

More Voices